Mads Krogsgaard Thomsen, CEO of Novo Nordisk Foundation, discusses European competitiveness.

European markets were subdued on Tuesday, with the STOXX 600 up 0.1 percent as healthcare and financials gains offset losses ...

(Reuters) -European shares rose on Tuesday, buoyed by gains in the healthcare and luxury sectors, but the uptick was tempered ...

(Reuters) - European shares were subdued on Tuesday, as rising financials and healthcare shares countered broader losses ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

European equities rose on Tuesday on relief that US President Donald Trump had refrained from immediately targeting the ...

European shares held steady with slight gains in financials and healthcare despite global uncertainties over U.S. President Donald Trump's proposed tariffs. The market's cautious optimism was ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

The Mexico-based hormone clinic, which has online capabilities is doing its part to meet increased global demand for ...

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...

EUROPEAN shares rose on Tuesday, buoyed by gains in the healthcare and luxury sectors, but the uptick was tempered by ...